Just One-in-Four CBD Topical Products in the US Are Accurately Labeled, Study Finds
As a result of their findings, the Johns Hopkins Medicine researchers say that improvements need to be made to the regulatory oversight of these products in order to ensure good product quality and prevent unwanted drug effects.
Green Scientific Labs Adopts LIMS Software
Green Scientific Labs, the multi-state cannabis testing company, has adopted a new laboratory information management system (LIMS) for immediate use across all its labs.
Senate Democrats Introduce a Cannabis Decriminalization Bill
If passed, the bill that would legislate the removal of the federal ban on cannabis, which could effectively decriminalize the drug across the nation.
Microdosing Cannabis Extract Shows “Encouraging” Results in Patient with Alzheimer’s Disease
A 75-year-old man with Alzheimer’s disease is successfully managing his symptoms with microdoses of cannabis, according to a new case report published in the Journal of Medical Case Reports.
First Trial of Transdermal CBD for Adult Epilepsy Reports Mixed Results
To confirm the findings, the researchers say that additional randomized controlled trials on transdermal CBD for adult focal epilepsy are warranted.
Industry-Friendly Cannabis Regulations in California Are Failing to Take Public Health Risks Seriously, Researchers Argue
A new viewpoint paper published by research scientists and public health experts in California warns that current cannabis regulations are not doing enough to protect public health.
Cannabis Smoke Damages Cells in the Mouth, Study Finds
New research published in the Archives of Oral Biology has found that cannabis smoke can damage the gingival epithelial cells in the mouth and suppress their proliferation.
What Should California Do About Cannabis Lab Shopping? The State’s Regulator Wants Your Help to Decide
California has a cannabis testing problem. The state's Department of Cannabis Control wants to fix it, and it's asking for help.
One Month of Psilocybin Microdosing Improves Mood and Mental Health, Study Suggests
The microdosers in the study generally reported less depression, stress, and anxiety after one month of use, compared to their non-microdosing peers.
